NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Stupp R, et al.：Eur J Cancer. 2012 Sep;48（14）:2192-202. doi: 10.1016/j.ejca.2012.04.011.